Evidence map›Paper›PMID 32964006›Full record

ArticleERJ open research2020

Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol.

Alexander G Mathioudakis, Fekri Abroug, Alvar Agusti, Per Bakke, Konstantinos Bartziokas, Bianca Beghe, Andras Bikov, Thomas Bradbury, Guy Brusselle, Cordula Cadus and 36 more

Abstract read
In one paragraph

Article in ERJ open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. COPD maintenance trials use heterogeneous outcomes and measurement instruments: a systematic literature review.European respiratory review : an official journal of the European Respiratory Society · 2026
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Giving Voice to People - Experiences During Mild to Moderate Acute Exacerbations of COPD.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Current developments and future directions in COPD.European respiratory review : an official journal of the European Respiratory Society · 2020
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors.

Alexander G MathioudakisDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.ORCID https://orcid.org/0000-0002-4675-9616
Fekri AbrougHospital Fattouma Bourguiba, Monastir, Tunisia.
Alvar AgustiInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), National Spanish Network for Respiratory Research (CIBERES), Barcelona, Spain.
Per BakkeDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Konstantinos BartziokasRespiratory Medicine Dept, University of Ioannina School of Medicine, Ioannina, Greece.
Bianca BegheSection of Respiratory Diseases, Dept of Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Andras BikovDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Thomas BradburyThe George Institute for Global Health, University of New South Wales, Sydney, Australia.
Guy BrusselleDepts of Epidemiology and Respiratory Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0001-7021-8505
Cordula CadusUniversity Department of Medicine, Cantonal Hospital Basell and Liestal, Basell, Switzerland.
Courtney ColemanEuropean Lung Foundation, Sheffield, UK.
Marco ContoliResearch Center on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy.
Alexandru CorlateanuDept of Respiratory Medicine, State University of Medicine and Pharmacy "Nicolae Testemitanu", Chisinau, Moldova.ORCID https://orcid.org/0000-0002-3278-436X
Olga CorlateanuDepartment of Internal Medicine, State University of Medicine and Pharmacy "Nicolae Testemitanu", Chisinau, Moldova.ORCID https://orcid.org/0000-0002-3278-436X
Gerard CrinerDept of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
Balazs CsomaDept of Pulmonology, Semmelweis University, Budapest, Hungary.
Alexander EmelyanovDept of Respiratory Medicine and Allergy, North-Western Medical University, St Petersburg, Russian Federation.
Rosa FanerInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), National Spanish Network for Respiratory Research (CIBERES), Barcelona, Spain.
Gustavo Fernandez RomeroDept of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
Zeineb HammoudaHospital Fattouma Bourguiba, Monastir, Tunisia.
Peter HorváthDept of Pulmonology, Semmelweis University, Budapest, Hungary.
Arturo Garcia HuertaInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), National Spanish Network for Respiratory Research (CIBERES), Barcelona, Spain.
Michael JacobsDept of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
Christine JenkinsThe George Institute for Global Health, University of New South Wales, Sydney, Australia.
Guy JoosDept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.ORCID https://orcid.org/0000-0002-3149-9444
Olga KharevichDept of Pulmonology and Tuberculosis, Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus.
Konstantinos KostikasRespiratory Medicine Dept, University of Ioannina School of Medicine, Ioannina, Greece.
Elena LaptevaDept of Pulmonology and Tuberculosis, Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus.
Zsofia LazarDept of Pulmonology, Semmelweis University, Budapest, Hungary.
Joerg D LeuppiUniversity Department of Medicine, Cantonal Hospital Basell and Liestal, Basell, Switzerland.
Carol LiddleEuropean Lung Foundation, Sheffield, UK.
Alejandra López-GiraldoInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), National Spanish Network for Respiratory Research (CIBERES), Barcelona, Spain.
Vanessa M McDonaldDept of Respiratory and Sleep Medicine, Medical and Interventional Services, John Hunter Hospital, Hunter New England Local Health District, New Lambton Heights, Australia.
Rune NielsenDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Alberto PapiResearch Center on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy.ORCID https://orcid.org/0000-0002-6924-4500
Isabel SaraivaEuropean Lung Foundation, Sheffield, UK.
Galina SergeevaDept of Respiratory Medicine and Allergy, North-Western Medical University, St Petersburg, Russian Federation.
Agni SioutkouRespiratory Medicine Dept, University of Ioannina School of Medicine, Ioannina, Greece.
Pradeesh SivapalanSection of Respiratory Medicine, Dept of Internal Medicine, Herlev-Gentofte Hospital, Hellerup, Denmark.
Elizabeth StovoldCochrane Airways Group, Population Health Research Institute, St George's University of London, London, UK.
Hao WangDept of Respiratory and Critical Care Medicine, West China Hospital/West China School of Medicine, Sichuan University, Chengdu, China.
Fuqiang WenDept of Respiratory and Critical Care Medicine, West China Hospital/West China School of Medicine, Sichuan University, Chengdu, China.
Janelle YorkeSchool of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Paula R WilliamsonLiverpool Clinical Trials Centre, Dept of Biostatistics, University of Liverpool, Liverpool, UK.
Jørgen VestboDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.ORCID https://orcid.org/0000-0001-6355-6362
Jens-Ulrik JensenSection of Respiratory Medicine, Dept of Internal Medicine, Herlev-Gentofte Hospital, Hellerup, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Randomised controlled trials (RCTs) on the management of COPD exacerbations evaluate heterogeneous outcomes, often omitting those that are clinically important and patient relevant. This limits their usability and comparability. A core outcome set (COS) is a consensus-based minimum set of clinically important outcomes that should be evaluated in all RCTs in specific areas of health care. We present the study protocol of the COS-AECOPD ERS Task Force, aiming to develop a COS for COPD exacerbation management, that could remedy these limitations. For the development of this COS we follow standard methodology recommended by the COMET initiative. A comprehensive list of outcomes is assembled through a methodological systematic review of the outcomes reported in relevant RCTs. Qualitative research with patients with COPD will also be conducted, aiming to identify additional outcomes that may be important to patients, but are not currently addressed in clinical research studies. Prioritisation of the core outcomes will be facilitated through an extensive, multi-stakeholder Delphi survey with a global reach. Selection will be finalised in an international, multi-stakeholder meeting. For every core outcome, we will recommend a specific measurement instrument and standardised time points for evaluation. Selection of instruments will be based on evidence-informed consensus. Our work will improve the quality, usability and comparability of future RCTs on the management of COPD exacerbations and, ultimately, the care of patients with COPD. Multi-stakeholder engagement and societal support by the European Respiratory Society will raise awareness and promote implementation of the COS.

Identifiers

PMID32964006
PMCPMC7487360

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.